BMA vs GGAL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

BMA

56.1
AI Score
VS
BMA Wins

GGAL

52.3
AI Score

Investment Advisor Scores

BMA

56score
Recommendation
STRONG BUY

GGAL

52score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BMA GGAL Winner
Forward P/E 3.0979 3.3102 BMA
PEG Ratio 0.4681 0.1751 GGAL
Revenue Growth 1.2% -7.9% BMA
Earnings Growth 3.5% 12.0% GGAL
Tradestie Score 56.1/100 52.3/100 BMA
Profit Margin 9.0% 1.5% BMA
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY STRONG BUY Tie

Relative Price Performance (Last 90 Days)

BMA 1M: -9.8% · 3M: -30.6% GGAL 1M: -7.5% · 3M: -26.8%

Current Technical Phase

BMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.7%), weak momentum, RSI 38

RSI (14): 38.5 · Price: $64.03

GGAL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.7%), weak momentum, RSI 43

RSI (14): 42.7 · Price: $36.61

Fundamentals Snapshot

Metric BMA GGAL
Market Cap — —
Forward P/E 0.0 5.1
Trailing P/E 13.2 41.4
Revenue (TTM) — —
Revenue Growth 0.0% -0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.3% 0.2%
EPS 4.89 0.89
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.